Average Insider

Where insiders trade, we follow

Parabilis Medicines, Inc. ($PBLS)
Accession: 0001193805-26-000798
Jun 12, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$24.51
Current$28.8343.3% above low, 56.7% below high
52W High$34.47

Filing Information

Accession Number0001193805-26-000798
Form Type4
Filing DateJun 12, 2026
DocumentView SEC Filing
Transactions
16
Total Shares
3,922,708
Total Value
$0.00

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion122,990โ€”โ€”122,990IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion122,990โ€”โ€”122,990IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion149,238โ€”โ€”272,228IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion149,238โ€”โ€”272,228IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion260,992โ€”โ€”533,220IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion260,992โ€”โ€”533,220IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion407,132โ€”โ€”940,352IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Voting Common Stock
โ€”Jun 11, 2026Conversion407,132โ€”โ€”940,352IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Series A Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion166,070โ€”โ€”0IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Series A Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion166,070โ€”โ€”0IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Series B Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion143,650โ€”โ€”0IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Series B Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion143,650โ€”โ€”0IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Series C Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion246,732โ€”โ€”0IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Series C Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion246,732โ€”โ€”0IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Flynn James E
10% Owner
Series D Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion464,550โ€”โ€”0IndirectThrough Deerfield Private Design Fund III, L.P.View Details
Flynn James E
10% Owner
Series D Preferred Stock
(Voting Common Stock)
DerivativeJun 11, 2026Conversion464,550โ€”โ€”0IndirectThrough Deerfield Healthcare Innovations Fund, L.P.View Details
Version: v26.7.3